Platform Specialty Products to acquire Chemtura
Platform Specialty Products Corporation, a global specialty chemicals company, announced that it has entered into a definitive agreement to acquire Chemtura AgroSolutions, a leading and fast-growing global provider of agrochemicals and seed treatment products, from Chemtura Corporation for approximately $1 billion, consisting of $950 million in cash, subject to working capital and other adjustments, plus 2 million shares of Platform’s common stock.
CAS is a leading provider of seed treatment and agrochemical products for a wide variety of crop applications in attractive geographies. Its portfolio encompasses seed treatments, insecticides, miticides, herbicides, fungicides, plant growth regulators and adjuvants, and is supported by a proven and robust new product pipeline with over 100 new launches in each of the last three years. These products, backed by extensive research and field testing, utilize advanced formulations to enhance crop quality and yield in many specialty markets and are supported by product registrations in more than 100 countries.
CAS has delivered profitable growth and should be immediately accretive by more than 35% to Platform’s adjusted earnings, pre-synergies. For the year ended December 31, 2013, Chemtura reported net sales for CAS business of approximately $449 million and adjusted EBITDA of $101 million, representing an adjusted EBITDA margin of 22.6%, which is in line with Platform’s margin profile. CAS has demonstrated a strong track record of earnings expansion since the economic downturn, as evidenced by its EBITDA compounded annual growth rate of over 15% from 2009 through 2013, primarily from organic growth.
Similar to Platform’s MacDermid business, CAS requires modest capital investment to maintain its growth trajectory, as typically less than 2% of annual net sales is used for capital expenditures. CAS’ senior leadership team, led by its President, Nelson Gibson, possesses on average, more than 25 years of agricultural experience and will remain with the business.
Platform will pursue a virtual Active Ingredient (“AI”) model, and Platform and Chemtura have entered into a long-term supply agreement where Chemtura will supply key AI’s. Platform will supplement this with select acquisition and licensing of others AI’s to take advantage of CAS’ global registrations and distribution footprint.
Martin Franklin, Platform’s founder and chairman, said, “When Platform made its initial investment with the acquisition of MacDermid last year, we recognized that the specialty chemicals space was ripe with opportunity for assembling a portfolio of best-in-class companies, and CAS has many of the same attractive business characteristics as MacDermid. CAS’ strong positions in niche markets extend our reach into a new vertical, which possesses robust growth dynamics. This is a successful, fast-growing business with an experienced management team, and the additional resources and guidance from Platform’s executive leadership should provide CAS with an optimal, long-term home for it to truly thrive.”
- CLA identifies areas for EPA to enhance effectiveness of WPS
- Ukraine to lose 15% of grain crop in violence-hit regions
- POET set to open its cellulosic ethanol plant
- 'Plantibodies' drugs advance as big pharma stands aside
- Did we miss the boat on corn plant population in 2014?
- Falling livestock futures grabbing headlines Wednesday morning
- Suspected Bt corn rootworm resistance in Pennsylvania
- No El Niño in 2014? Drought-weary California in trouble
- BioNitrogen to build second fertilizer plant in Texas
- Soybean aphid numbers on the rise
- Commentary: Setting the record straight on 'Waters of the U.S.'
- FCC aims to offer high-speed internet to rural America